Engerix- B Ped is a vaccine designed to prevent hepatitis B virus infection. It stimulates children's immune systems to produce antibodies that prevent infection with this virus, which can cause chronic hepatitis and serious complications such as cirrhosis or liver cancer. The vaccine is usually given as part of the basic vaccination schedule at an early age to ensure protection from the first months of life. It is highly effective and provides long-lasting immunity when all prescribed doses are completed.
Engerix- B Ped is administered by intramuscular injection in doses distributed over specific time intervals to ensure the best immune response. It may be accompanied by some minor symptoms, such as redness or swelling at the injection site or a slight increase in temperature. These symptoms usually subside within a short time. It is always recommended to adhere to all dose schedules and follow up with a healthcare provider to maintain full protection against hepatitis B virus.